3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
24
Ovarian Neoplasms
16
Lung Neoplasms
15
Breast Neoplasms
14
Endometrial Neoplasms
13
Parkinson Disease 4, Autosomal Dominant Lewy Body
12
Fallopian Tube Neoplasms
10
Squamous Cell Carcinoma of Head and Neck
8
Neoplasm Metastasis
8
Triple Negative Breast Neoplasms
5
Esophageal Neoplasms
5
Adenocarcinoma Of Esophagus
5
Stomach Neoplasms
4
Neoplasms
4
Melanoma
4
Esophageal Squamous Cell Carcinoma
4
Colorectal Neoplasms
3
Carcinoma
3
Uterine Cervical Neoplasms
2
Urinary Bladder Neoplasms
2
Peritoneal Neoplasms
2
Cholangiocarcinoma
2
Carcinoma, Transitional Cell
2
Brenner Tumor
2
Anatomic Stage I Breast Cancer AJCC v8
2
Advanced Solid Tumour
2
Adenocarcinoma, Bronchiolo-Alveolar
2
Adenocarcinoma of Lung
2
Adenocarcinoma
2
Uterine Neoplasms
1
Interventions
lutetium Lu 177 dotatate
5
Specimen Handling
3
Magnetic Resonance Spectroscopy
3
pembrolizumab
2
olaparib
2
fludarabine
2
cabozantinib
2
X-Rays
2
Phantoms, Imaging
2
Cyclophosphamide
2
tivozanib
1
repotrectinib
1
pazopanib
1
fludarabine phosphate
1
entrectinib
1
belinostat
1
atezolizumab
1
aldesleukin
1
Yttrium-90
1
Tomography, X-Ray Computed
1
Tomography, Emission-Computed, Single-Photon
1
Temozolomide
1
Single Photon Emission Computed Tomography Computed Tomography
1
Salts
1
Positron Emission Tomography Computed Tomography
1
PT-100 dipeptide
1
Octreotide
1
Nivolumab
1
Introns
1
Interferon alpha-2
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Neuroendocrine Tumors
×
Paclitaxel
×
30 days
×
Clear all
No trials found.